Cabot Corporation $CBT Shares Sold by Leeward Investments LLC MA

Leeward Investments LLC MA trimmed its holdings in Cabot Corporation (NYSE:CBT) by 5.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 207,597 shares of the specialty chemicals company’s stock after selling 12,559 shares during the period. Leeward Investments LLC MA owned about 0.40% of Cabot worth $15,966,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in CBT. Root Financial Partners LLC purchased a new stake in shares of Cabot during the 3rd quarter worth approximately $27,000. Northwestern Mutual Wealth Management Co. bought a new stake in Cabot in the 2nd quarter valued at about $33,000. Global Retirement Partners LLC purchased a new stake in Cabot during the second quarter valued at about $88,000. Rockefeller Capital Management L.P. lifted its holdings in Cabot by 115.3% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,152 shares of the specialty chemicals company’s stock valued at $76,000 after purchasing an additional 617 shares during the last quarter. Finally, Allworth Financial LP bought a new position in Cabot during the second quarter worth about $145,000. 93.18% of the stock is owned by institutional investors.

Cabot Stock Performance

Shares of CBT opened at $73.86 on Monday. Cabot Corporation has a 52-week low of $58.33 and a 52-week high of $94.53. The stock’s 50-day simple moving average is $79.05 and its 200 day simple moving average is $82.49. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The stock has a market capitalization of $3.81 billion, a price-to-earnings ratio of 20.80, a price-to-earnings-growth ratio of 8.69 and a beta of 0.83.

Cabot (NYSE:CBT) last posted its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%. The business had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. During the same quarter in the previous year, the firm earned $1.90 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Research analysts forecast that Cabot Corporation will post 6.35 EPS for the current fiscal year.

Wall Street Analyst Weigh In

CBT has been the subject of several recent research reports. Truist Financial set a $100.00 target price on shares of Cabot in a research note on Wednesday, August 5th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, October 11th. UBS Group cut their price objective on shares of Cabot from $92.00 to $86.00 and set a “neutral” rating for the company in a report on Monday, October 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Friday, August 21st. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research note on Friday, August 7th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $87.80.

Insider Activity at Cabot

In other news, CEO Sean Keohane sold 134,895 shares of the firm’s stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares in the company, valued at approximately $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold 229,597 shares of company stock valued at $19,646,746 in the last three months. 3.08% of the stock is currently owned by company insiders.

Cabot Company Profile

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.